Skip to content
Use caution Drug recall · FDA · Published December 12, 2012

Boehringer Ingelheim Recalls Perindopril Erbumine 8mg Tablets

Boehringer Ingelheim recalls 3,553 bottles of Perindopril Erbumine 8mg tablets due to out-of-specification impurity levels. Check your lot number.

🇺🇸 FDA recall #D-126-2013DrugBoehringer Ingelheim Roxane ›
Take action

Contact the company

Recalling firmBoehringer Ingelheim Roxane Inc1809 Wilson Rd · Columbus, OH 43228-9579
✎ GovInfoNow plain-language explainer

Boehringer Ingelheim Roxane Inc is recalling Perindopril Erbumine Tablets, 8mg, specifically the 100-tablet bottles with NDC 0054-0112-25. The recall was issued because testing found out-of-specification results for impurity B, which is the drug's metabolite. This issue affects Lot #160017A, which has an expiration date of April 2013. Read more at govinfonow.com/recall/48450-boehringer-ingelheim-roxane-inc-recalls-perindopril-erbumine-tablets-8mg-100.

Source Summary by GovInfoNow · govinfonow.com/recall/48450-boehringer-ingelheim-roxane-inc-recalls-perindopril-erbumine-tablets-8mg-100 · Updated October 13, 2026 · FDA enforcement record: FDA #D-126-2013

Cite this page

“Boehringer Ingelheim Recalls Perindopril Erbumine 8mg Tablets.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48450-boehringer-ingelheim-roxane-inc-recalls-perindopril-erbumine-tablets-8mg-100. Based on FDA recall #D-126-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-126-2013%22&limit=1).

Boehringer Ingelheim Roxane Inc voluntarily recalled Perindopril Erbumine Tablets, 8mg, due to out-of-specification impurity levels, the FDA said on Dec. 12, 2012. The recall affects 3,553 bottles distributed nationwide.

How to tell if you have it

  • Brand: Boehringer Ingelheim Roxane
  • Product: Perindopril Erbumine Tablets 8mg
  • NDC: 0054-0112-25
  • Lot #: 160017A
  • Expiration: 04/2013
  • Quantity: 100 Tablets per Bottle

The hazard

The FDA reported that impurity B, identified as the drug's metabolite, was found in out-of-specification results. The recall is classified as Class III.

Context

GovInfoNow's records show Boehringer Ingelheim Roxane Inc has 12 other recalls on record since 2012-11-05. Other recent recalls of similar products include FUROSEMIDE Tablets USP (2015-09-25), Combivent Respimat (2015-07-24), and Acarbose 50mg Tablets (2015-04-02). Other recent recalls of similar products include Unichem Bisoprolol/Hydrochlorothiazide Tablets (2026-01-21), JB Chemicals Enalapril tablets (2026-04-23), and Breckenridge Duloxetine Capsules (2025-11-24).

How to tell if you have this one

Check your medication bottle for NDC 0054-0112-25 and Lot #160017A. The product is Perindopril Erbumine Tablets, 8mg, sold in bottles of 100 tablets. It was distributed nationwide.

  • Brand
    Boehringer Ingelheim Roxane
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if your bottle has NDC 0054-0112-25 and Lot #160017A with an expiration date of April 2013.

  2. Contact your pharmacist

    If you have the recalled lot, speak with your pharmacist or healthcare provider about replacing the medication.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 18 months after the firm started it.

1. Firm started the recall: Dec 12, 201212. FDA classified it Class III: Jan 16, 201323. Published in FDA’s Enforcement Report: Jan 23, 201334. FDA terminated the recall: Jun 16, 2014420122014
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-126-2013 (December 12, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-126-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA